Synairgen Limited logo
VerifiedBiotechnology· Founded 2003

Synairgen Limited

Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit

7-day free trial · no credit card

HeadquartersSouthampton, United KingdomEmployees23(51 to 200)Founded year2003Websitesynairgen.comLinkedIn profileLinkedIn

Verified contacts

23

available on Kipplo

LinkedIn employees

23

51 to 200 range

Open roles

no listings

Distinct roles

19

indexed titles

Tech stack

0

tools in use

Monthly traffic

402

organic / mo

Sign up free to see all 23 verified contacts at Synairgen Limited

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

23 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Synairgen Limited

19 distinct titles indexed · top 10 shown.

  • 2research assistant
  • 1administration assistant
  • 1chief executive officer
  • 1chief regulatory officer
  • 1clinical finance business partner
  • 1clinical research associate
  • 1clinical research nurse
  • 1director of cmc
  • 1hr manager
  • 1office administrator
  • +9more titles

Sign up to unlock all 23 contacts at Synairgen Limited

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 23 verified contacts at Synairgen Limited

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Synairgen Limited | Kipplo Discover